NM_003119.4:c.1933T>A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BP4_Strong

The NM_003119.4(SPG7):​c.1933T>A​(p.Ser645Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000812 in 1,606,910 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00074 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00082 ( 0 hom. )

Consequence

SPG7
NM_003119.4 missense

Scores

2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1

Conservation

PhyloP100: 4.22

Publications

7 publications found
Variant links:
Genes affected
SPG7 (HGNC:11237): (SPG7 matrix AAA peptidase subunit, paraplegin) This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014]
SPG7 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 7
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 2 benign, 6 uncertain in NM_003119.4
BP4
Computational evidence support a benign effect (MetaRNN=0.022359908).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPG7NM_003119.4 linkc.1933T>A p.Ser645Thr missense_variant Exon 14 of 17 ENST00000645818.2 NP_003110.1 Q9UQ90-1
SPG7NM_001363850.1 linkc.1933T>A p.Ser645Thr missense_variant Exon 14 of 18 NP_001350779.1
SPG7XM_047434537.1 linkc.1060T>A p.Ser354Thr missense_variant Exon 9 of 13 XP_047290493.1
SPG7XM_047434540.1 linkc.619T>A p.Ser207Thr missense_variant Exon 6 of 9 XP_047290496.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPG7ENST00000645818.2 linkc.1933T>A p.Ser645Thr missense_variant Exon 14 of 17 NM_003119.4 ENSP00000495795.2 Q9UQ90-1

Frequencies

GnomAD3 genomes
AF:
0.000736
AC:
112
AN:
152192
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000911
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.000818
AC:
191
AN:
233420
AF XY:
0.000687
show subpopulations
Gnomad AFR exome
AF:
0.000208
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000984
Gnomad NFE exome
AF:
0.00119
Gnomad OTH exome
AF:
0.000693
GnomAD4 exome
AF:
0.000820
AC:
1193
AN:
1454600
Hom.:
0
Cov.:
31
AF XY:
0.000799
AC XY:
578
AN XY:
723048
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33274
American (AMR)
AF:
0.00172
AC:
75
AN:
43714
Ashkenazi Jewish (ASJ)
AF:
0.0000771
AC:
2
AN:
25926
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39316
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
85080
European-Finnish (FIN)
AF:
0.000209
AC:
11
AN:
52700
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5752
European-Non Finnish (NFE)
AF:
0.000960
AC:
1064
AN:
1108760
Other (OTH)
AF:
0.000516
AC:
31
AN:
60078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
65
129
194
258
323
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000735
AC:
112
AN:
152310
Hom.:
1
Cov.:
33
AF XY:
0.000779
AC XY:
58
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41572
American (AMR)
AF:
0.00248
AC:
38
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000911
AC:
62
AN:
68022
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000837
Hom.:
0
Bravo
AF:
0.000835
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.000693
AC:
84

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia Uncertain:2
Mar 07, 2017
Unit for Genetic & Epidemiological Research on Neurological Disorders, Instituto de Investigação e Inovação em Saúde
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

Dec 01, 2018
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:2
Jul 08, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified as heterozygous without a second variant in SPG7 in several individuals with hereditary spastic paraplegia; in one family, the authors did not consider the variant disease causing as it was absent in at least one affected family member (Elleuch et al., 2006; Arnoldi et al., 2008; Morais et al., 2017).; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 22571692, 27535533, 28832565, 18200586, 16534102) -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 7 Uncertain:1Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Retinal dystrophy Uncertain:1
Jan 01, 2022
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
13
DANN
Benign
0.11
DEOGEN2
Benign
0.16
.;.;T;.;.;.;.;.;.
Eigen
Benign
-0.79
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.81
T;T;T;T;T;T;T;T;T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.022
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
-1.6
.;.;N;.;.;.;.;.;.
PhyloP100
4.2
PrimateAI
Uncertain
0.56
T
REVEL
Uncertain
0.36
Polyphen
0.0030
.;.;B;.;.;.;.;.;.
MVP
0.51
MPC
0.19
ClinPred
0.018
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.5
Varity_R
0.093
gMVP
0.71
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2099104; hg19: chr16-89619540; API